Bayesian adaptive clinical trial designs for respiratory medicine
- PMID: 35918280
- PMCID: PMC9544135
- DOI: 10.1111/resp.14337
Bayesian adaptive clinical trial designs for respiratory medicine
Abstract
The use of Bayesian adaptive designs for clinical trials has increased in recent years, particularly during the COVID-19 pandemic. Bayesian adaptive designs offer a flexible and efficient framework for conducting clinical trials and may provide results that are more useful and natural to interpret for clinicians, compared to traditional approaches. In this review, we provide an introduction to Bayesian adaptive designs and discuss its use in recent clinical trials conducted in respiratory medicine. We illustrate this approach by constructing a Bayesian adaptive design for a multi-arm trial that compares two non-invasive ventilation treatments to standard oxygen therapy for patients with acute cardiogenic pulmonary oedema. We highlight the benefits and some of the challenges involved in designing and implementing Bayesian adaptive trials.
Keywords: Bayesian adaptive design; Bayesian methods; adaptive trial; clinical trials; interim analysis; monitoring.
© 2022 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.
Conflict of interest statement
None declared.
Figures
References
-
- Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health‐care evaluation. Chichester: John Wiley & Sons; 2004.
-
- Berry SM, Carlin BP, Lee JJ, Muller P. Bayesian adaptive methods for clinical trials. Boca Raton: CRC Press; 2011.
-
- Kruschke JK. Doing Bayesian data analysis: a tutorial with R, JAGS, and Stan. London: Elsevier/Academic Press; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
